332
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Slicing parameter optimization for 3D printing of biodegradable drug-eluting tracheal stents

, &
Pages 650-658 | Received 17 Dec 2019, Accepted 06 Feb 2020, Published online: 17 Feb 2020

References

  • Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. 2016. Emergence of 3D printed dosage forms: opportunities and challenges. Pharm Res. 33(8):1817–1832.
  • Arrhenius SA. 1889. Über die Reaktionsgeschwindigkeit bei der Inversion von Rohrzucker durch Säuren. Z Phys Chem. 4:226–248.
  • Ben-Ner A, Siemsen E. 2017. Decentralization and localization of production: the organizational and economic consequences of additive manufacturing (3D printing). Calif Manag Rev. 59(2):5–23.
  • Bode C, Kranz H, Fivez A, Siepmann F, Siepmann J. 2019. Often neglected: PLGA/PLA swelling orchestrates drug release: HME implants. J Control Release. 306:97–107.
  • Chia HN, Wu BM. 2015. Recent advances in 3D printing of biomaterials. J Biol Eng. 9(1):4.
  • DIN EN ISO 527-1. 2012. Kunststoffe – Bestimmung der Zugeigenschaften – Teil 1: Allgemeine Grundsätze (ISO 527-1). [accessed 2020 Feb 13]. https://www.din.de/de.
  • EDQM. 2019a. European Directorate for the Quality of Medicines – Council of Europe. European Pharmacopoeia. 9th ed., 4.1.3 buffer solutions. [accessed 2020 Feb 13]. https://www.edqm.eu/.
  • EDQM. 2019b. European Directorate for the Quality of Medicines – Council of Europe. European Pharmacopoeia. 9th ed., 2.9.40 Uniformity of dosage units. [accessed 2020 Feb 13]. https://www.edqm.eu/.
  • EDQM. 2019c. European Directorate for the Quality of Medicines – Council of Europe. European Pharmacopoeia. 9th ed., triamterene monograph. [accessed 2020 Feb 13]. https://www.edqm.eu/.
  • Evonik. 2019. RESOMER product portfolio; [accessed 2019 Jul 18]. https://healthcare.evonik.com/product/healthcare/en/products/biomaterials/resomer/pages/controlled-release.aspx.
  • Feuerbach T, Callau-Mendoza S, Thommes M. 2019. Development of filaments for fused deposition modeling 3D printing with medical grade poly(lactic-co-glycolic acid) copolymers. Pharm Dev Technol. 24(4):487–493.
  • Feuerbach T, Kock S, Thommes M. 2018. Characterisation of fused deposition modeling 3D printers for pharmaceutical and medical applications. Pharm Dev Technol. 23(10):1136–1145.
  • Freitag L, Eicker R, Linz B, Greschuchna D. 1994. Theoretical and experimental basis for the development of a dynamic airway stent. Eur Respir J. 7(11):2038–2045.
  • Freitag L, Gordes M, Zarogoulidis P, Darwiche K, Franzen D, Funke F, Hohenforst-Schmidt W, Dutau H. 2017. Towards individualized tracheobronchial stents: technical, practical and legal considerations. Respiration. 94(5):442–456.
  • Goyanes A, Scarpa M, Kamlow M, Gaisford S, Basit AW, Orlu M. 2017. Patient acceptability of 3D printed medicines. Int J Pharm. 530(1–2):71–78.
  • Habibovic P, Gbureck U, Doillon C J, Bassett D C, Van Blitterswijk C A, Barralet J E. 2008. Osteoconduction and osteoinduction of low-temperature 3D printed bioceramic implants. Biomaterials. 29(7):944–953.
  • Holländer J, Genina N, Jukarainen H, Khajeheian M, Rosling A, Mäkilä E, Sandler N. 2016. Three-dimensional printed PCL-based implantable prototypes of medical devices for controlled drug delivery. J Pharm Sci. 105(9):2665–2676.
  • Jonathan G, Karim A. 2016. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int J Pharm. 499:376–394.
  • Kempin W, Franz C, Koster LC, Schneider F, Bogdahn M, Weitschies W, Seidlitz A. 2017. Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants. Eur J Pharm Biopharm. 115:84–93.
  • Long J, Gholizadeh H, Lu J, Bunt C, Seyfoddin A. 2017. Application of Fused Deposition Modelling (FDM) Method of 3D Printing in Drug Delivery. Curr Pharm Des. 23(3):433–439.
  • Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 3(3):1377–1397.
  • McKittrick CM, Kennedy S, Oldroyd KG, McGinty S, McCormick C. 2016. Modelling the impact of atherosclerosis on drug release and distribution from coronary stents. Ann Biomed Eng. 44(2):477–487.
  • Melgoza EL, Vallicrosa G, Sereno L, Ciurana J. 2014. Rapid tooling using 3D printing system for manufacturing of customized tracheal stent. Rapid Prototyp J. 20(1):2–12.
  • Melocchi A, Parietti F, Loreti G, Maroni A, Gazzaniga A, Zema L. 2015. 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs. J Drug Deliv Sci Technol. 30:360–367.
  • Noppen M, Meysman M, Claes I, D’Haese J, Vincken W. 1999. Screw-thread vs Dumon endoprosthesis in the management of tracheal stenosis. Chest. 115(2):532–535.
  • Petrick IJ, Simpson TW. 2013. 3D printing disrupts manufacturing: how economies of one create new rules of competition. Res Technol Manage. 56(6):12–16.
  • Pruessmann K, Wentzlaff M, Schilling R, Seidlitz A. 2019. Influence of dissolution vessel geometry and dissolution medium on in vitro dissolution behaviour of triamterene-coated model stents in different test setups. AAPS PharmSciTech. 20(1):27.
  • Sandler N, Preis M. 2017. Printed drug-delivery systems for improved patient treatment. Trends Pharmacol Sci. 38(3):317–319.
  • Schubert C, van Langeveld MC, Donoso LA. 2014. Innovations in 3D printing: a 3D overview from optics to organs. Br J Ophthalmol. 98(2):159–161.
  • Sequeira JAD, Santos AC, Serra J, Veiga F, Ribeiro AJ. 2018. Poly(lactic-co-glycolic acid) (PLGA) matrix implants. In: Grumezescu AM, editor. Nanostructures for the engineering of cells, tissues and organs. 1st ed. Norwich: William Andrew Publishing; p. 375–402.
  • Sereno L, Freitas MS, Silveria Z, Silva JVL, Ciurana J. 2013. New advances in tracheal stent manufacturing. 6th IFAC Conference on Management and Control of Production and Logistics. IFAC Proc Vol. 46(24):344–349.
  • Shafiee A, Atala A. 2016. Printing technologies for medical applications. Trends Mol Med. 22(3):254–265.
  • Sharma R, Singh R, Penna R, Fraternali F. 2018. Investigations for mechanical properties of Hap, PVC and PP based 3D porous structures obtained through biocompatible FDM filaments. Composites B. 132:237–243.
  • Skowyra J, Pietrzak K, Alhnan MA. 2015. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur J Pharm Sci. 68:11–17.
  • Taboas JM, Maddox RD, Krebsbach PH, Hollister SJ. 2003. Indirect solid free form fabrication of local and global porous, biomimetic and composite 3D polymer–ceramic scaffolds. Biomaterials. 24(1):181–194.
  • Ventola CL. 2014. Medical applications for 3D printing: current and projected uses. P T. 39(10):704–711.
  • Wang L, Gardner DJ. 2017. Effect of fused layer modelling (FLM) processing parameters on impact strength of cellular polypropylene. Polymer. 113:74–80.
  • Zein I, Hutmacher DW, Tan KC, Teoh SH. 2002. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials. 23(4):1169–1185.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.